Segmentation by type classifies Ultrasound Physiotherapy Equipment according to design architecture, power output, and integration capability, thereby influencing capital allocation and unit‑price variance. Therapeutic ultrasound devices—stand‑alone units delivering continuous or pulsed frequencies between 0.75 MHz and 3 MHz—dominates the market, accounting for roughly 45 % of shipments due to their proven efficacy in deep‑tissue heating and proven clinical protocols. Diagnostic ultrasound devices, though primarily employed for imaging, are increasingly bundled with therapeutic modules, contributing about 10 % of revenue as multidisciplinary clinics seek combined assessment and treatment solutions. Portable handheld units represent a fast‑growing segment (≈20 %) driven by outpatient and home‑care demand for lightweight, battery‑operated systems with adjustable intensity settings. Tabletop systems—larger, fixed‑position platforms used in hospitals and rehabilitation centers—hold approximately 15 % of the market, reflecting higher power outputs and integrated monitoring features. Integrated rehabilitation platforms, which embed ultrasound transducers within robotic or exoskeleton frameworks, capture the remaining 10 %, illustrating early‑stage adoption but high‑margin potential. This type‑based market taxonomy elucidates product‑line diversification and guides manufacturers’ R&D prioritization.